These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2560913)

  • 1. The canyon hypothesis.
    Rossmann MG
    Viral Immunol; 1989; 2(3):143-61. PubMed ID: 2560913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance.
    Rossmann MG
    J Biol Chem; 1989 Sep; 264(25):14587-90. PubMed ID: 2670920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance.
    Chapman MS; Rossmann MG
    Virology; 1993 Aug; 195(2):745-56. PubMed ID: 8337843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of a human rhinovirus complexed with its receptor molecule.
    Olson NH; Kolatkar PR; Oliveira MA; Cheng RH; Greve JM; McClelland A; Baker TS; Rossmann MG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):507-11. PubMed ID: 8093643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic and cryo EM analysis of virion-receptor interactions.
    Rossmann MG; Olson NH; Kolatkar PR; Oliveira MA; Cheng RH; Greve JM; McClelland A; Baker TS
    Arch Virol Suppl; 1994; 9():531-41. PubMed ID: 7913361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation of the putative receptor attachment site in picornaviruses.
    Rossmann MG; Palmenberg AC
    Virology; 1988 Jun; 164(2):373-82. PubMed ID: 2835857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different rhinovirus serotypes neutralized by antipeptide antibodies.
    McCray J; Werner G
    Nature; 1987 Oct 22-28; 329(6141):736-8. PubMed ID: 2444889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.
    Che Z; Olson NH; Leippe D; Lee WM; Mosser AG; Rueckert RR; Baker TS; Smith TJ
    J Virol; 1998 Jun; 72(6):4610-22. PubMed ID: 9573224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cellular receptor interactions in poliovirus and rhinoviruses.
    Xing L; Tjarnlund K; Lindqvist B; Kaplan GG; Feigelstock D; Cheng RH; Casasnovas JM
    EMBO J; 2000 Mar; 19(6):1207-16. PubMed ID: 10716921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.
    Kolatkar PR; Bella J; Olson NH; Bator CM; Baker TS; Rossmann MG
    EMBO J; 1999 Nov; 18(22):6249-59. PubMed ID: 10562537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
    Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
    J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral cell recognition and entry.
    Rossmann MG
    Protein Sci; 1994 Oct; 3(10):1712-25. PubMed ID: 7849588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid.
    Tresnan DB; Southard L; Weichert W; Sgro JY; Parrish CR
    Virology; 1995 Aug; 211(1):123-32. PubMed ID: 7645206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of human rhinovirus serotype 1A (HRV1A).
    Kim SS; Smith TJ; Chapman MS; Rossmann MC; Pevear DC; Dutko FJ; Felock PJ; Diana GD; McKinlay MA
    J Mol Biol; 1989 Nov; 210(1):91-111. PubMed ID: 2555523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhinoviral receptor discrimination: mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction.
    Duechler M; Ketter S; Skern T; Kuechler E; Blaas D
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2287-91. PubMed ID: 8409953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.
    Colonno RJ; Callahan PL; Long WJ
    J Virol; 1986 Jan; 57(1):7-12. PubMed ID: 3001366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
    Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
    Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of single receptor molecules bound to human rhinovirus under physiological conditions.
    Kienberger F; Rankl C; Pastushenko V; Zhu R; Blaas D; Hinterdorfer P
    Structure; 2005 Sep; 13(9):1247-53. PubMed ID: 16154082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of the human intercellular adhesion molecule-1, the human rhinovirus major group receptor.
    Giranda VL; Chapman MS; Rossmann MG
    Proteins; 1990; 7(3):227-33. PubMed ID: 1972986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK; Basu S; Cherian SS
    Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.